Brassington, J. C. & Marsh, N. V. (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychology Review, 8, 43–77.
Canter, A. H. (1951) Direct and indirect measures of psychological deficit in multiple sclerosis. Part 1. Journal of General Psychology, 44, 3–25.
Chacko, R. C., Hurley, R. A., Harper, R. G.
et al (1995) Clozapine for acute and maintenance treatment of psychosis in Parkinsons disease. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 471–475.
Charcot, J. M. (1877) Lectures on the Diseases of the Nervous System, Delivered at La Salpetriere. London: New Sydenham Society.
Chwastiak, L., Ehde, D. M., Gibbons, L. E.
et al (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. American Journal of Psychiatry, 159, 1862–1868.
Cottrell, S. S. & Wilson, S. A. K. (1926) The affective symptomatology of disseminated sclerosis. Journal of Neurology and Psychopathology, 7, 1–30.
Davison, K. & Bagley, C. R. (1969) Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of the literature. In Current Problems in Neuropsychiatry: Schizophrenia, Epilepsy, the Temporal Lobe (ed. Herrington, R. N.) pp. 113–184. London: Headley.
Fassbender, K. & Schmidt, R. (1998) Mood disorders and dysfunction of the hypothalamic–pituitary–adrenal axis in multiple sclerosis. Archives of Neurology, 55, 66–72.
Feinstein, A. (1999) The Clinical Neuropsychiatry of Multiple Sclerosis. Cambridge: Cambridge University Press.
Feinstein, A. (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology, 59, 674–678.
Feinstein, A., du Boulay, G. & Ron, M. A. (1992) Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. British Journal of Psychiatry, 161, 680–685.
Feinstein, A., Feinstein, K. J., Gray, T.
et al (1997) The prevalence and neurobehavioral correlates of pathological laughter and crying in multiple sclerosis. Archives of Neurology, 54, 1116–1121.
Feinstein, A., O'Connor, P. & Feinstein, K. (2002) Multiple sclerosis, interferon beta-1b and depression. A prospective investigation. Journal of Neurology, 249, 815–820.
Ford, H., Trigwell, P. & Johnson, M. (1998) The nature of fatigue in multiple sclerosis. Journal of Psychosomatic Research, 45, 33–38.
Franklin, G. M., Heaton, R. K., Nelson, L. M.
et al (1988) Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurology, 38, 1826–1829.
Furmaga, K. M., DeLeon, O. & Sinha, S. (1995) Risperidine response in refractory psychosis due to a general medical condition. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 417.
Goldman Consensus Group (2005) The Goldman Consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 11, 328–337.
Janardhan, V. & Bakshi, R. (2002) Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of Neurological Sciences, 205, 51–58.
Kahana, E., Liebowitz, U. & Alter, M. (1971) Cerebral multiple sclerosis. Neurology, 21, 1179–1185.
Krupp, L. B., Christodoulou, C., Melville, P.
et al (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology, 63, 1579–1585.
Krystal, A. D. & Coffey, C. E. (1997) Neuropsychiatric considerations in the use of electroconvulsive therapy. Journal of Neuropsychiatry and Clinical Neurosciences, 145, 366–371.
Larcombe, N. A. & Wilson, P. H. (1984) An evaluation of cognitive–behaviour therapy for depression in patients with multiple sclerosis. British Journal of Psychiatry, 145, 366–371.
Mattingly, G., Baker, K., Zorumski, C. F.
et al (1992) Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 145–151.
McIntosh-Michaelis, S. A., Roberts, M. H., Wilkinson, S. M.
et al (1991) The prevalence of cognitive impairment in a community survey of multiple sclerosis. British Journal of Clinical Psychology, 30, 333–348.
Michelson, D., Stone, L., Galliven, E.
et al (1994) Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. Journal of Clinical Endocrinology and Metabolism, 79, 848–853.
Minden, S. L. & Schiffer, R. B. (1990) Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Archives of Neurology, 54, 531–533.
Moran, P. J. & Mohr, D. C. (2005) The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. Journal of Behavioral Medicine, 28, 35–41.
Patten, S. B., Jacobs, P., Petcu, R.
et al (2002). Major depressive disorder as a direct cost determinant in multiple sclerosis. International Journal of Psychiatry in Medicine, 32, 167–178.
Rabins, P. V. (1990) Euphoria in multiple sclerosis. In Neuro-behavioural Aspects of Multiple Sclerosis (ed. Rao, S. M.) New York: Oxford University Press.
Rao, S. M., Leo, G. J., Bernadin, L.
et al (1991) Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns and prediction. Neurology, 41, 685–691.
Sadovnick, A. D.
Eisen, K., Ebers, G. C.
et al (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology, 41, 1193–1196.
Schiffer, R. B. & Wineman, N. M. (1990) Antidepressant pharmaco-therapy of depression associated with multiple sclerosis. American Journal of Psychiatry, 147, 1493–1497.
Schiffer, R. B., Herndon, R. M. & Rudick, R. A. (1985) Treatment of pathologic laughing and weeping with amitriptyline. New England Journal of Medicine, 312, 1480–1482.
Schiffer, R. B., Wineman, M. & Weitkamp, L. R. (1986) Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry, 143, 94–105.
Schwartz, C. E., Coulthard-Morris, L. & Qi Zeng, M. S. (1996) Psychosocial correlates of fatigue in multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 77, 165–170.
Scott, T. F., Nussbaum, P., McConnell, H.
et al (1995) Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurological Research, 17, 421–422.
Seliger, G. M., Hornstein, A., Flax, J.
et al (1992) Fluoxetine improves emotional incontinence. Brain Injury, 6, 267–270.
Sloan, R. L., Brown, K. W. & Pentland, B. (1992) Fluoxetine as a treatment for emotional lability after brain injury. Brain Injury, 6, 315–319.
Stenager, E. N., Stenager, E., Koch-Henriksen, N.
et al (1992) Suicide and multiple sclerosis: an epidemiological investigation. Journal of Neurology, Neurosurgery and Psychiatry, 55, 542–545.
Surridge, D. (1969) An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry, 115, 749–764.
Udaka, F., Yamao, S., Nagata, H.
et al (1984) Pathologic laughing and crying treated with levodopa. Archives of Neurology, 41, 1095–1096.
Wei, T. & Lightman, S. L. (1997) The neuroendocrine axis in patients with multiple sclerosis. Brain, 120, 1067–1076.
Young, C. R., Weiss, E. L., Bowers, M. B. Jr.
et al (1997) The differential diagnosis of multiple sclerosis and bipolar disorder. Journal of Clinical Psychiatry, 58, 123.